NK cell


Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.
Related to NK cell: mast cell, B cell, T cell

NK cell

(ĕn′kā′)
Mentioned in ?
References in periodicals archive ?
To directly demonstrate that soluble factors and not cell to cell contact were responsible for the MSC-mediated inhibition of NK cell cytotoxicity against LLC1 cells, effects of MSC-CM were evaluated.
Herein, we examined the effects of JTT on NK cell activity and metastasis following combined treatment with anti-PD-1 antibody in a B16 transplantation model of metastasis.
Albany, NY, August 18, 2016 --(PR.com)-- Market Research HUB has announced the addition of the "TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016" report to their huge collection of market research reports.
None of the patients had genetic testing, sCD25 levels or NK cell activity testing.
Both companies will work together on the generation and evaluation of up to two bispecific NK cell engagers, using technology from Innate Pharma and Sanofi's proprietary bispecific antibody format as well as tumor targets.
The factors contributing to NK cell dysfunction were demonstrated by many studies.
(OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company's proprietary NK cell engager (TriKE) platform and Multi-Target Directed Bispecific Drug Conjugate platform, announced today that Jeffrey Miller, M.D.
Additionally, the Company is leveraging its assets to develop an early-stage pipeline of multifaceted, next-generation NK cell therapies targeting hematological malignancies and solid tumors, including its ReOpt-NK (Retargeted Optimized NK cell) therapy.
They tested these tumor organoids and organoids from healthy colon cells to see how effectively different CAR NK cell lines destroy colon cancer cells, and what damage they might cause including in healthy cells.
"The ligand on the surface of target cells (infected or tumor cells) triggers NK cell cytotoxicity and activates the receptors on the NK cells.
Previous scientific wisdom has discredited combining virotherapy and externally added NK cell therapy to the body's natural killer (NK) cells, but there could be clear cancer-fighting benefits -- providing enough external NK cells are deployed to destroy the tumor and stop its spread, as revealed in the paper published this week in Proceedings of the National Academy of Sciences.
The receptors that are responsible for NK cell activation during the process of natural cytotoxicity are collectively termed natural cytotoxicity receptors (NCRs).